Skip to content
10-Q

Quarterly Report

ANIXA BIOSCIENCES, INC. ANIX

0001493152-24-022573

← back to feed
Filed
Jun 4, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jun 4, 2024 32.01M sh
Short Term Investments Q2 2024 · Apr 30, 2024 $22.24M
Short Term Investments Q2 2024 · Oct 31, 2023 $22.93M
Cash And Equivalents Q2 2024 · Apr 30, 2024 $995K
Cash And Equivalents Q2 2024 · Oct 31, 2023 $915K
Stockholders Equity Q2 2024 · Apr 30, 2024 $23.62M
Stockholders Equity Q2 2024 · Oct 31, 2023 $24.34M
Current Liabilities Q2 2024 · Apr 30, 2024 $1.68M
Current Liabilities Q2 2024 · Oct 31, 2023 $2.03M
Total Liabilities Q2 2024 · Apr 30, 2024 $1.77M
Total Liabilities Q2 2024 · Oct 31, 2023 $2.15M
Current Assets Q2 2024 · Apr 30, 2024 $24.21M
Current Assets Q2 2024 · Oct 31, 2023 $25.36M
Total Assets Q2 2024 · Apr 30, 2024 $24.36M
Total Assets Q2 2024 · Oct 31, 2023 $25.52M
Shares Diluted Q2 2024 · Apr 30, 2023 30.93K sh
Shares Diluted Q2 2024 · Apr 30, 2023 30.92K sh
Operating Cash Flow Q2 2024 · Apr 30, 2023 −$2.8M
Eps Diluted Q2 2024 · Apr 30, 2023 −$0.07
Eps Diluted Q2 2024 · Apr 30, 2023 −$0.15
Eps Basic Q2 2024 · Apr 30, 2023 −$0.07
Eps Basic Q2 2024 · Apr 30, 2023 −$0.15
Rd Expense Q2 2024 · Apr 30, 2023 $998K
Rd Expense Q2 2024 · Apr 30, 2023 $2.07M
Net Income Q2 2024 · Apr 30, 2023 −$2.29M
Net Income Q2 2024 · Apr 30, 2023 −$4.61M
Operating Income Q2 2024 · Apr 30, 2023 −$2.56M
Operating Income Q2 2024 · Apr 30, 2023 −$5.12M
Revenue Q2 2024 · Apr 30, 2023 $210K
Revenue Q2 2024 · Apr 30, 2023 $210K